Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Blood flow restriction training to improve recovery after Achilles tendon repair

Official title: Optimizing Rehabilitation After Achilles Tendon Rupture Repair: The Role of Blood Flow Restriction Training in Tendon and Muscle Recovery

Run by University Hospital, Ghent · NCT07131787 · Data updated 2026-11-12

This trial will test whether adding blood flow restriction training to standard rehabilitation helps adults recover muscle strength and tendon function after surgical repair of an Achilles tendon rupture.

More Achilles Tendon Rupture trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment82 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations2 sites (Ghent, East-Flanders and 1 other locations)
StatusRecruiting
StartedAugust 20, 2025
Main results expectedMay 2028
Study endsNovember 2028
Registry record updatedSeptember 23, 2025
Trial IDNCT07131787 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 who had surgical repair of a midportion Achilles tendon rupture, can understand Dutch, and have no medical conditions that would prevent exercise or BFR are the intended candidates.

Probably not a fit

Patients with bilateral or prior Achilles ruptures, diabetes, rheumatic disease, prior deep venous thrombosis, severe cardiovascular disease, or other leg conditions limiting exercise may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled trial will compare rehabilitation with blood flow restriction (BFR) to conventional strength training in adults who have had surgical repair for a midportion Achilles tendon rupture at two Ghent hospitals. Participants start a supervised 24-week exercise program beginning four weeks after surgery and are assigned to either standardized strength training with a smart-cuff pro BFR device or the same program without BFR. Outcomes include functional recovery, muscle strength, and tendon-related measures assessed clinically and with imaging over the follow-up period. The trial is conducted at Ghent University and Ghent University Hospital with follow-up visits at those sites.

Why it matters

Potential benefit: If successful, adding BFR to rehab could speed strength recovery and improve tendon healing, helping patients return to daily activities and sports sooner.

How similar studies have gone: BFR has shown promise for improving muscle strength in other orthopedic rehabilitation settings, but its specific benefit after Achilles tendon repair is not yet well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with total midrupture Achilles tendon rupture
* surgical treatment
* \> 18 years old
* able to understand and speak Dutch

Exclusion Criteria:

* Bilateral Achilles tendon rupture
* Previous Achilles tendon rupture
* Previous treatment with fluoroquinolones or cortisone
* other condition in either leg that would limit the ability to perform the exercises or evaluations
* Diabetes or rheumatic diseases
* History of deep venous thrombosis
* severe cardiovascular disease

Where it's running

  • Ghent University Hospital
    Ghent, Belgium
    Recruiting
  • Ghent University
    Ghent, East-Flanders, Belgium
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.